In vitro diagno substances, reagents
Ended Awarded Last action
- Contract number
- HHSN261201000071I
- Awardee
-
Melanoma Institute Australia UEI F5FEF8JTK7X6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $192,500 obligated
Award facts
- Opportunity
-
- RECOVERY: Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $192,500 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 96% used
- $200,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to the Melanoma Institute Australia. The $192,500 firm fixed-price delivery order contract, part of the NCI's Cancer Genome Atlas (TCGA) program, involves the collection of tissue samples and data from various types of cancer. This work was funded under the American Recovery and Reinvestment Act (ARRA) and does not have a set-aside designation. The contract's period of performance runs from the award date of September 17, 2010 through the ultimate completion date of September 30, 2014, with performance taking place in Australia. The contract is a task order under the broader NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Arra::yes::arra recovery act tissue samples and data from various types of cancer for the cancer genome atlas (TCGA)… | National Cancer Institute (NIH) | $192,500 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000071I?
HHSN261201000071I was awarded to Melanoma Institute Australia by National Cancer Institute (National Institutes of Health) on September 3, 2010.
How much is contract HHSN261201000071I worth?
Orders under HHSN261201000071I have obligated $192,500. HHSN261201000071I's own ceiling is $200,000.
How many orders have been placed under contract HHSN261201000071I?
1 order has been placed under HHSN261201000071I, the latest on September 17, 2010.
Who can order from contract HHSN261201000071I?
HHSN261201000071I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000071I part of a contract vehicle?
Yes. HHSN261201000071I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000071I competed?
The extent of competition for HHSN261201000071I was competed under sap. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV